China A-share innovative drug sector extended gains. Wanbang Pharma earlier sealed the board at the limit-up; Shuanglu Pharmaceutical, Kangyuan Pharmaceutical and Asymchem hit 10% limit-up. Jiangsu Hengrui Medicine advanced more than 8%; WuXi AppTec, Changshan Pharmaceutical and other drug names also rose.

On the 28th Russian President Putin told the United Russia party congress Russia is at a pivotal moment and the West cannot defeat it on the battlefield; attempts to destabilize domestic politics will fail. He said Russia will firmly defend its core interests, has adjusted some development targets to reflect realities but will fully deliver its strategic plans, and will guarantee state and citizen security and the inviolability of its borders. He said the State Duma election will be held on schedule in accordance with the law and has ordered agencies to secure the vote and guard against external manipulation.

Zhongtai Securities says the market will likely hold a clear bottom and consolidate over the next one to two weeks. After major IPO listings, falling uncertainty and repaired sentiment could lift the market toward prior highs or new highs. Leadership is expected to remain a diffusion across technology names rather than a broad style rotation. High-conviction tech plays: storage, semiconductor equipment and the overseas compute chain, with storage and chip equipment seen as most certain. Non-tech pockets to watch: new energy, AI-related specialty materials and minor metals, construction machinery and securities brokers. New energy is supported medium-term by higher power demand from AI compute expansion and export demand. In AI materials, a price upcycle in copper-clad laminate (CCL) has begun. Brokers should benefit from IPO cornerstone buying and higher trading activity, offering tactical swing opportunities.